Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05434572 · ClinicalTrials.gov registry record
CIMR Neuromuscular Research Biobank
A clinical trial of Neuromuscular Diseases and Neuromuscular Disorder, sponsored by Virginia Commonwealth University.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT05434572: Recruiting study of Neuromuscular Diseases and Neuromuscular Disorder, sponsored by Virginia Commonwealth University.
NCT05434572 is a study of Neuromuscular Diseases and Neuromuscular Disorder that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 500 participants, above the 98-participant average among 15 other Neuromuscular Diseases trials with a reported enrollment target (410% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05434572, a study of Neuromuscular Diseases and Neuromuscular Disorder, is actively recruiting participants, sponsored by Virginia Commonwealth University.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research repository is to collect, store, and share with other researchers any tissues that subjects with all types of neuromuscular disease are willing to donate. These samples will be stored at Virginia Commonwealth University (VCU) and will be used for future research with this population.
Primary Outcome
Subjects will have the opportunity to provide the following samples: saliva or cheek swab, urine sample (up to 15ml), feces (up to 2mg of a stool sample), blood (up to 40ml), muscle biopsy tissue, and cell line (subjects have the option to allow a cell line to be made from their blood, muscle, or skin biopsies to provide a renewable supply of DNA and other cell components for research)
Conditions Studied
Study Locations (1)
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2021-03-17 |
| Est. Completion | 2030-02 |
What NCT05434572 shows while recruiting
NCT05434572 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 98-participant average among 15 other Neuromuscular Diseases trials with a reported enrollment target (410% higher).
The record links to 3 conditions, with Neuromuscular Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT05434572 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT05434572 about?
NCT05434572 is a clinical study titled "CIMR Neuromuscular Research Biobank". The purpose of this research repository is to collect, store, and share with other researchers any tissues that subjects with all types of neuromuscular disease are willing to donate. These samples will be stored at Virginia Commonwealth University (VCU) and will be used for future research with thi...
What is the current status of trial NCT05434572?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2021-03-17. Estimated completion is 2030-02.
What conditions does trial NCT05434572 study?
This clinical trial studies the following conditions: Neuromuscular Diseases, Neuromuscular Disorder, Neuromuscular Diseases in Children.
Who is sponsoring clinical trial NCT05434572?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05434572 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuromuscular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05434572's enrollment target sits among peer trials
500 1st of 15 higher than 15 of 15 other Neuromuscular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neuromuscular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients
RECRUITING · Phase 2
-
Genesis Electrical Impedance Tomography (EIT): A Preliminary Study
RECRUITING
-
A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4J
RECRUITING
-
Spastic Paraplegia - Centers of Excellence Research Network
RECRUITING
-
Non-Invasive Respiratory Monitor
RECRUITING · NA
-
Measuring Physical Activity With ActivPal
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI